Denmark· DK-28105504414

Repatha

A evolocumab product containing evolocumab, registered in Denmark by Amgen Europe BV. The same ATC class is registered in 15 of our 19 countries.

ATC C10AX13

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedRepathaATCC10AX13REGISTER NO.DK-28105504414PACKS LISTED1CHECKEDSeptember 30, 2026

Where it is registered

Evolocumab is registered in 15 of 19 countries.

Countries holding a registration under ATC C10AX13 (evolocumab), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 10 of them publish a price we can compare per daily dose

Evolocumab · ATC C10AX13

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of evolocumab costs, country by country.

Normalised to the WHO defined daily dose (10 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Evolocumab · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$17.24
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
Evolocumab
Manufacturer
Amgen Europe BV
Country
Denmark (DK)
ATC code
C10AX13
ATC class
Evolocumab
Defined daily dose
10 mg, P
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28105504414

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d33291c9-149c-446c-b590-1c3ddb432d41
GET /v1/drugs/d33291c9-149c-446c-b590-1c3ddb432d41?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "injektionsvæske, opløsning i fyldt injektionssprøjte",
  "source": "dkma",
  "strength": "140 mg",
  "auth_role": "MOD",
  "dk_drugid": "28105504414",
  "substance": "Evolocumab",
  "auth_procedure": "Central",
  "in_medicinpriser": false,
  "registration_date_serial": "42202"
}

See everything about evolocumab.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.